-
September 23: The Week in Cancer News
AACR Cancer Progress Report 2022 shows continued decline in cancer death rates, and genetic tests create opportunities but also confusion for breast cancer patients.
by Eric Fitzsimmons
-
September 16: The Week In Cancer News
Air pollution research provides clues to how cancer starts, and KRAS-targeting drug appears to keep cancer at bay longer than standard of care, but questions remain
by Marci A. Landsmann
-
September 9: The Week in Cancer News
Early-onset cancer is increasing globally, and testing population-wide preventive DNA testing.
by Kevin McLaughlin
-
September 2: The Week in Cancer News
Fertility preservation does not impact outcomes for breast cancer patients, and ultraprocessed foods linked to increased risk of colorectal cancer in men.
by Thomas Celona
-
August 26: The Week in Cancer News
Advanced cervical cancer rates are rising despite prevention and screening tools, and CAR T-cell therapy inaccessible to many across the country.
by Eric Fitzsimmons
-
August 19: The Week in Cancer News
Link found between fracking wells and leukemia in children, and accurate reporting of cancer outcomes urged for Native Hawaiians and Pacific Islanders.
by Kevin McLaughlin
-
August 12: The Week in Cancer News
Drug for HER2-positive cancer receives further approvals, and researchers study the risk of lung cancer from wildfires.
by Marci A. Landsmann
-
August 5: The Week in Cancer News
Study finds majority of patients treated with chemotherapy experience hearing loss, and ‘rogue’ online pharmacies found to be dispensing oncology drugs.
by Thomas Celona
-
July 29: The Week in Cancer News
Cancer patients and doctors concerned about how abortion bans will affect treatment, and resistant starch supplements lower risk of many cancers in people with Lynch syndrome.
by Eric Fitzsimmons
-
July 22: The Week in Cancer News
Drug shortages in hematology oncology, and cancer centers don’t accept Medicaid.
by Marci A. Landsmann
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore